Trial no.:
|
PACTR202402674777836 |
Date of Approval:
|
15/02/2024 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effects of Caffeine Ingestion on Endurance Performance, Psychological state, and Oxidative Stress Status in Young Recreational Runners |
Official scientific title |
Low-dose Caffeine Ingestion Improves Exhaustive Endurance Performance and does not Affect Oxidative Stress Markers in Young Recreational Runners |
Brief summary describing the background
and objectives of the trial
|
Background:
Caffeine has been widely used in endurance sports owing to its performance-enhancing impact. However, its main effect on oxidative stress induced by such efforts is still unclear.
Purpose
This study aimed to examine the effects of low-dose caffeine ingestion on performance and oxidative stress markers (i.e., glutathione peroxidase (GPX), reduced glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA)) after an exhaustive endurance exercise in 13 recreational runners being physical education students.
|
Type of trial |
Observational |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Physical activity and nutrition |
Anticipated trial start date |
30/01/2024 |
Actual trial start date |
30/01/2024 |
Anticipated date of last follow up |
20/03/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
13 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|